Filing Details

Accession Number:
0001277997-10-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-02 15:10:30
Reporting Period:
2010-11-30
Filing Date:
2010-12-02
Accepted Time:
2010-12-02 15:10:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277994 P L Iv Fund Entrepreneurs Venrock C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1277997 P L Iv Associates Venrock C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305238 Venrock Management Iv, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305239 Venrock Partners, L.p. C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305240 Venrock Partners Management, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305243 Vef Management Iv, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-30 1,752,808 $0.00 1,752,808 No 4 C Indirect By Funds
Common Stock Acquisiton 2010-11-30 133,622 $0.00 1,886,430 No 4 C Indirect By Funds
Common Stock Acquisiton 2010-11-30 139,105 $0.00 2,025,535 No 4 C Indirect By Funds
Common Stock Acquisiton 2010-11-30 600,000 $5.00 2,625,535 No 4 P Indirect By Funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Funds
No 4 C Indirect By Funds
No 4 C Indirect By Funds
No 4 P Indirect By Funds
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Convertible Preferred Stock Disposition 2010-11-30 1,752,808 $0.00 1,752,808 $0.00
Common Stock Series D Convertible Preferred Stock Disposition 2010-11-30 133,622 $0.00 133,622 $0.00
Common Stock Series E Convertible Preferred Stock Disposition 2010-11-30 139,105 $0.00 139,105 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of the Issuer's Series C Convertible Preferred Stock, Series D Convertible Preferred Stock and Series E Convertible Preferred Stock automatically converted into shares of common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering.
  2. The Issuer's Series C Convertible Preferred Stock, Series D Convertible Preferred Stock and Series E Convertible Preferred Stock do not have an expiration date and automatically converted into shares of common stock upon the closing of the Issuer's initial public offering.
  3. The shares, on a post conversion basis, were converted as follows: 1,426,786 shares held by Venrock Associates IV, L.P. ("VAIV"), 290,966 shares held by Venrock Partners, L.P. ("VP") and 35,056 shares held by Venrock Entrepreneurs Fund IV, L.P. ("VEFIV"). Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC (together, the "Venrock GP Entities") are the sole general partners of VAIV, VP and VEFIV, respectively (together, the "Venrock Funds"), and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.
  4. The shares, on a post conversion basis, were converted as follows: 108,769 shares held by VAIV, 22,181 shares held by VP and 2,672 shares held by VEFIV. Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC are the sole general partners of VAIV, VP and VEFIV, respectively, and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.
  5. The shares, on a post conversion basis, were converted as follows: 113,232 shares held by VAIV, 23,091 shares held by VP and 2,782 shares held by VEFIV. Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC are the sole general partners of VAIV, VP and VEFIV, respectively, and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.
  6. The shares are held as follows: 1,426,786 shares held by VAIV, 290,966 shares held by VP and 35,056 shares held by VEFIV. Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC are the sole general partners of VAIV, VP and VEFIV, respectively, and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.
  7. The shares are held as follows: 1,535,555 shares held by VAIV, 313,147 shares held by VP and 37,728 shares held by VEFIV. Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC are the sole general partners of VAIV, VP and VEFIV, respectively, and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.
  8. The shares are held as follows: 1,648,787 shares held by VAIV, 336,238 shares held by VP and 40,510 shares held by VEFIV. Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC are the sole general partners of VAIV, VP and VEFIV, respectively, and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.
  9. The shares were purchased as follows: 488,400 shares purchased by VAIV, 99,600 shares purchased by VP and 12,000 shares purchased by VEFIV. Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC are the sole general partners of VAIV, VP and VEFIV, respectively, and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.
  10. The shares are held as follows: 2,137,187 shares held by VAIV, 435,838 shares held by VP and 52,510 shares held by VEFIV. Venrock Management IV, LLC, Venrock Partners Management, LLC and VEF Management IV, LLC are the sole general partners of VAIV, VP and VEFIV, respectively, and have voting and investment power over the shares held by the Venrock Funds. Each of the Venrock GP Entities disclaims beneficial ownership of the shares held by the Venrock Funds, except to the extent of its respective indirect pecuniary interest therein.